On this page
John Pratt
Insider
First SEC filing: March 14, 2013 · Latest: March 14, 2013
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 13, 2013 | PCRX | M | 1,875 | · | · | 18,750 Direct | -9.09% | Disposed | (price as of 2026-10-02) |
| June 13, 2013 | PCRX | M | 18,232 | · | · | 112,500 Direct | -13.95% | Disposed | (price as of 2026-10-02) |
| June 13, 2013 | PCRX | S | 1,875 | $30.00 | $56,250 | 0 Direct | -100.00% | Disposed | -16.0% (price as of 2026-10-02) |
| June 13, 2013 | PCRX | M | 1,875 | $8.73 | $16,369 | 1,875 Direct | · | Acquired | 188.8% (price as of 2026-10-02) |
| June 13, 2013 | PCRX | S | 18,232 | $30.00 | $546,960 | 0 Direct | -100.00% | Disposed | -16.0% (price as of 2026-10-02) |
| June 13, 2013 | PCRX | M | 18,232 | $10.81 | $197,088 | 18,232 Direct | · | Acquired | 133.2% (price as of 2026-10-02) |
| June 12, 2013 | PCRX | M | 925 | · | · | 130,732 Direct | -0.70% | Disposed | (price as of 2026-10-02) |
| June 12, 2013 | PCRX | S | 925 | $30.00 | $27,750 | 0 Direct | -100.00% | Disposed | -16.0% (price as of 2026-10-02) |
| June 12, 2013 | PCRX | M | 925 | $10.81 | $9,999 | 925 Direct | · | Acquired | 133.2% (price as of 2026-10-02) |
| June 11, 2013 | PCRX | M | 12,945 | · | · | 131,657 Direct | -8.95% | Disposed | (price as of 2026-10-02) |
| June 11, 2013 | PCRX | S | 12,945 | $30.00 | $388,350 | 0 Direct | -100.00% | Disposed | -16.0% (price as of 2026-10-02) |
| June 11, 2013 | PCRX | M | 12,945 | $10.81 | $139,935 | 12,945 Direct | · | Acquired | 133.2% (price as of 2026-10-02) |
| June 10, 2013 | PCRX | M | 5,398 | · | · | 144,602 Direct | -3.60% | Disposed | (price as of 2026-10-02) |
| June 10, 2013 | PCRX | S | 5,398 | $30.00 | $161,940 | 0 Direct | -100.00% | Disposed | -16.0% (price as of 2026-10-02) |
| June 10, 2013 | PCRX | M | 5,398 | $10.81 | $58,352 | 5,398 Direct | · | Acquired | 133.2% (price as of 2026-10-02) |
| March 12, 2013 | PCRX | M | 9,375 | · | · | 20,625 Direct | -31.25% | Disposed | (price as of 2026-10-02) |
| March 12, 2013 | PCRX | S | 9,375 | $28.46 | $266,812 | 0 Direct | -100.00% | Disposed | -11.4% (price as of 2026-10-02) |
| March 12, 2013 | PCRX | M | 9,375 | $8.73 | $81,844 | 9,375 Direct | · | Acquired | 188.8% (price as of 2026-10-02) |
| June 5, 2012 | PCRX | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2012 | PCRX | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 13, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $8.73 | Jan. 2, 2022 | 1,875 | Disposed |
| June 13, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $10.81 | June 4, 2022 | 18,232 | Disposed |
| June 12, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $10.81 | June 4, 2022 | 925 | Disposed |
| June 11, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $10.81 | June 4, 2022 | 12,945 | Disposed |
| June 10, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $10.81 | June 4, 2022 | 5,398 | Disposed |
| March 12, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock | $8.73 | Jan. 2, 2022 | 9,375 | Disposed |
| June 5, 2012 | PCRX | Common Stock | Common Stock | $10.81 | June 4, 2022 | 150,000 | Acquired |
| Jan. 3, 2012 | PCRX | Employee Stock Option (right to buy) | Common Stock | $8.73 | Jan. 2, 2022 | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).